Apr 10, 2014

High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm

Clinical Pharmacology and Therapeutics
Sony Tuteja, Daniel J Rader

Abstract

High-density-lipoprotein cholesterol (HDL-C) has been identified in population studies as an independent inverse predictor of cardiovascular events. Although the causal nature of this association has been questioned, HDL and its major protein, apolipoprotein (apo)A1, have been shown to prevent and reverse atherosclerosis in animal models. In addition, HDL and apoA1 have several putatively atheroprotective functions, such as the ability to promote efflux of cholesterol from macrophages in the artery wall, inhibit vascular inflammation, and enhance endothelial function. Therefore, HDL-C and apoA1 have been investigated as therapeutic targets for coronary heart disease. However, recent clinical trials with drugs that raise HDL-C, such as niacin and inhibitors of cholesteryl ester transfer protein, have been disappointing. Here, we review the current state of the science regarding HDL as a therapeutic target.

Mentioned in this Paper

Epicholesterol
Vascular Inflammations
CETP protein, human
Apolipoprotein Measurement
APOA1 gene
Apolipoprotein Activity
Coronary Arteriosclerosis
Cardiovascular Diseases
Vascular Diseases
Atherosclerosis

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Lancet
Daniel J Rader, G Kees Hovingh
Current Atherosclerosis Reports
Ernst J Schaefer, Bela F Asztalos
© 2020 Meta ULC. All rights reserved